Post Transplant Study - Full Text View

Post Transplant Study

This study has been completed.

Sponsored by:	Amgen
Information provided by:	Amgen
ClinicalTrials.gov Identifier:	NCT00395902

Purpose

Retrospective chart review to gather information on Sensipar patterns of use and effects on biochemical parameters in renal transplant recipients

Condition	Intervention
Kidney Tansplant Secondary Hyperparathyroidism Hyperparathyroidism	Drug: Sensipar after Post Transplant

MedlinePlus related topics:

Kidney Transplantation

ChemIDplus related topics:

Cinacalcet Cinacalcet hydrochloride

U.S. FDA Resources

Study Type:	Observational
Study Design:	Retrospective

Official Title:	A Retrospective Evaluation of Sensipar Use in Renal Transplant Recipients

Further study details as provided by Amgen:

Estimated Enrollment:	50
Study Start Date:	August 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Inclusion Criteria:

Adults >= 18 years old
Subjects who have received Sensipar for a duration of at least 3 months, beginning at least 3 months after a kidney transplant. Subjects must have begun Sensipar teatment no later than Februry 28, 2005 at treating physician's discretion.

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00395902

Sponsors and Collaborators

Amgen

Investigators


Study Director:	MD	Amgen

More Information

AmgenTrials clinical trials website This link exits the ClinicalTrials.gov site

Responsible Party:	Amgen Inc. ( Global Development Leader )
Study ID Numbers:	20040261, 2004261
First Received:	November 2, 2006
Last Updated:	December 20, 2007
ClinicalTrials.gov Identifier:	NCT00395902
Health Authority:	United States: Institutional Review Board

Keywords provided by Amgen:

Sensipar

cinacalcet

Mimpara

Study placed in the following topic categories:

Parathyroid Diseases

Hyperparathyroidism, Secondary

Hyperparathyroidism

Neoplasm Metastasis

Endocrine System Diseases

Endocrinopathy

ClinicalTrials.gov processed this record on September 23, 2008